205 results on '"Omura, Junichi"'
Search Results
2. Patient and Therapeutic Profiles of Pulmonary Hypertension in Chronic Lung Diseases in Japan: A Cohort Study Using a Claims Database
3. Comparative Treatment Persistence and Adherence to Endothelin Receptor Antagonists Among Patients with Pulmonary Arterial Hypertension in Japan: A Real-World Administrative Claims Database Study
4. Correction: Patient and Therapeutic Profiles of Pulmonary Hypertension in Chronic Lung Diseases in Japan: A Cohort Study Using a Claims Database
5. Transcriptional profiling unveils molecular subgroups of adaptive and maladaptive right ventricular remodeling in pulmonary hypertension
6. 17β-estradiol and estrogen receptor-α protect right ventricular function in pulmonary hypertension via BMPR2 and apelin
7. Real-world diagnostic landscape and incidence of pulmonary hypertension in adult congenital heart disease patients using administrative claims data in Japan
8. PARP1-PKM2 Axis Mediates Right Ventricular Failure Associated With Pulmonary Arterial Hypertension
9. Correction: Patient and Therapeutic Profiles of Pulmonary Hypertension in Chronic Lung Diseases in Japan: A Cohort Study Using a Claims Database
10. Abstract 15564: Transcriptional Profiling Unveils New Molecular Subgroups of Adaptive and Maladaptive Right Ventricular Remodeling in Pulmonary Hypertension
11. Patient and Therapeutic Profiles of Pulmonary Hypertension in Chronic Lung Diseases in Japan: A Cohort Study Using a Claims Database
12. Identification of Celastrol As a Novel Therapeutic Agent for Pulmonary Arterial Hypertension and Right Ventricular Failure Through Suppression of Bsg (Basigin)/CyPA (Cyclophilin A)
13. Real‐world clinical practice of pulmonary arterial hypertension in Japan: Insights from a large administrative database
14. Different roles of myocardial ROCK1 and ROCK2 in cardiac dysfunction and postcapillary pulmonary hypertension in mice
15. Diagnostic and Prognostic Significance of Serum Levels of SeP (Selenoprotein P) in Patients With Pulmonary Hypertension
16. Abstract 17034: The AKT/AMPK/FOXO3 Axis in Pulmonary Arterial Hypertension
17. Abstract 16770: The Epigenetic Modifier EP300: A New Corner Stone in the Regulation of Both Vascular Remodeling and Right Ventricle Failure in Pulmonary Arterial Hypertension
18. Abstract 15621: Checkpoint Kinases Important Players in Lung Fibrogenesis and Pulmonary Vascular Remodeling: A Translational Study
19. Abstract 15259: Breast Cancer and Heritable Pah Due to Bmpr2 Mutation: An Unexpected Discovery
20. Abstract 13700: Role of Parp1-pkm2 Axis in the Pathogenesis of Right Ventricular Failure Associated With Pulmonary Arterial Hypertension
21. Identification of Emetine as a Therapeutic Agent for Pulmonary Arterial Hypertension: Novel Effects of an Old Drug
22. ADAMTS8 Promotes the Development of Pulmonary Arterial Hypertension and Right Ventricular Failure: A Possible Novel Therapeutic Target
23. 17[beta]-estradiol and estrogen receptor a protect right ventricular function in pulmonary hypertension via BMPR2 and apelin
24. SmgGDS Prevents Thoracic Aortic Aneurysm Formation and Rupture by Phenotypic Preservation of Aortic Smooth Muscle Cells
25. Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease
26. Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension: High-Throughput Screening of 5562 Compounds
27. Small GTP-Binding Protein GDP Dissociation Stimulator Prevents Thoracic Aortic Aneurysm Formation and Rupture by Phenotypic Preservation of Aortic Smooth Muscle Cells
28. Treatment pattern and clinical outcomes in portopulmonary hypertension: A database study in Japan
29. Long-term dietary nitrite and nitrate deficiency causes the metabolic syndrome, endothelial dysfunction and cardiovascular death in mice
30. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target
31. Abstract 17806: Protective Roles of Small GTP-binding Protein GDP Dissociation Stimulator Against Angiotensin II-induced Thoracic Aortic Aneurysm Formation And Rupture in Mice -A Possible Novel Therapeutic Target
32. Abstract 16256: Identification of Emetine as a Novel Therapeutic Agent for Pulmonary Hypertension in Rats -High-Throughput Screening of 5,562 Compounds
33. Abstract 16146: Rivaroxaban Prevents the Development of Chronic Thromboembolic Pulmonary Hypertension in Mice - Novel Beneficial Effects of the FXa Inhibitor
34. Abstract 16134: Different Roles of Myocardial ROCK1 and ROCK2 in Response to Chronic Pressure-Overload in Mice
35. Abstract 15047: Prognostic Impacts of Plasma Levels of Cyclophilin A in Patients With Heart Failure
36. Abstract 14863: ADAMTS8 Promotes the Development of Pulmonary Arterial Hypertension and Right Ventricular Failure-A Possible Novel Therapeutic Target
37. Abstract 14825: Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension -A Possible Novel Therapeutic Target
38. Abstract 10231: Parp1-Pkm2 Axis Mediates Right Ventricular Failure Associated with Pulmonary Arterial Hypertension
39. Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertension
40. Implication of EZH2 in the Pro-Proliferative and Apoptosis-Resistant Phenotype of Pulmonary Artery Smooth Muscle Cells in PAH: A Transcriptomic and Proteomic Approach
41. Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertension.
42. Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension
43. Identification of Adipsin as a Novel Prognostic Biomarker in Patients With Coronary Artery Disease
44. ERS International Congress 2019: highlights from Best Abstract awardees
45. Late Breaking Abstract - Inflammation and metabolic syndrome exacerbate pulmonary hypertension associated with left heart disease
46. Long Non-coding RNA H19 in Right Ventricular Failure associated with Pulmonary Arterial Hypertension
47. Implication of Enhancer of Zeste Homolog 2 in Pulmonary Arterial Hypertension
48. Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertension
49. Right ventricular and pulmonary vascular changes in pulmonary hypertension associated with left heart disease
50. Identification of Novel Therapeutic Targets for Pulmonary Arterial Hypertension
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.